6 completed, 3 active not recruiting, 2 recruiting, 2 unknown. 15 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 15 | Completed 6, Active not recruiting 3, Recruiting 2, Unknown 2, Withdrawn 2 |
Follow Elimination Disorders: new trials by email Literature Review of Elimination Disorders trials Research Report on Elimination Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Japanese Bridging Study of Autologous Muscle Derived Cells Compared to Placebo for Female Urinary Sphincter Repair(JPN1) AMDC-USR, Placebo - Stress Urinary Incontinence | Phase 3 | Withdrawn | Cook MyoSite | 2025-06-01 | 2024-08-27 | |
| Omegapres Versus Solifenacin and Mirabegron Combination Therapy in Treatment of Primary MNE Mirabegron (beta3-adrenoceptor agonist), Anticholinergics, Desmopressin (DDAVP) - Nocturnal Enuresis in Children | Phase 3 | Recruiting | Mansoura University | 120 | 2024-12-01 | 2025-09-30 |
| Efficacy of Solifenacin, Mirabegron and Combination Therapy in Children With Daytime Urinary Incontinence (BeDry) Solifenacin, Mirabegron - Urinary Incontinence in Children | Phase 3 | Recruiting | University of Aarhus | 236 | 2024-06-27 | 2026-06-08 |
| Iltamiocel Compared to Placebo for Chronic Fecal Incontinence in Females With Obstetric Injury Iltamiocel, Placebo - Fecal Incontinence | Phase 3 | Active not recruiting | Cook MyoSite | 200 | 2024-03-21 | 2026-10-20 |
| Neostigmine and Glycopyrrolate by Iontophoresis Combination of Neostigmine and Glycopyrrolate, I-Box by Dynatronics - Spinal Cord Injuries, Constipation | Phase 3 | Active not recruiting | James J. Peters Veterans Affairs Medical Center | 6 | 2020-11-06 | 2024-04-08 |
| The Safety and Efficacy of Fluoxetine for Refractory Primary Mono-symptomatic Nocturnal Enuresis in Children Fluoxetine, Placebo - Nocturnal Enuresis | Phase 3 | Unknown | Mansoura University | 100 | 2020-07-01 | 2020-12-19 |
| Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence AMDC-USR (iltamiocel), Placebo - Stress Urinary Incontinence | Phase 3 | Active not recruiting | Cook MyoSite | 96 | 2019-04-23 | 2026-10-21 |
| Treatment of Encopresis in Children With Autism Spectrum Disorders MIE Treatment, Glycerin Suppository, Treatment as Usual (TAU) - Encopresis, Autism Spectrum Disorder | Phase 3 | Completed | Emory University | 117 | 2017-10-25 | 2024-01-31 |
| A Clinical Study on Causticum 200 Centesimal Potency in Primary Enuresis Homoeopathic Medicine causticum 200c - Bed Wetting, Primary Enuresis | Phase 3 | Unknown | Fr Muller Homoeopathic Medical College | 50 | 2014-05-01 | 2014-06-03 |
| Minirin Versus Oxybutynin for Nocturnal Enuresis in Children Minirin, Oxybutynin - Nocturnal Enuresis | Phase 3 | Completed | Hormozgan University of Medical Sciences | 66 | 2013-07-01 | 2015-09-02 |
| UK Trial of Percutaneous Tibial Nerve Stimulation in Patients With Faecal Incontinence Percutaneous Tibial Nerve Stimulation - Faecal Incontinence, Bowel Incontinence | Phase 3 | Completed | Queen Mary University of London | 227 | 2012-01-01 | 2015-01-28 |
| Does the Negativation of the Glucose Hydrogen Breath Test Come Along With a Reduction of the Symptoms of Gaz Incontinence ? Metronidazole, CArbosylane - Anal Incontinence | Phase 3 | Completed | University Hospital, Rouen | 16 | 2011-01-01 | 2026-05-15 |
| Study With Two Different Doses of Desmopressin Orally Lyophilisate Tablet With Nocturnal Enuresis Desmopressin, Placebo - Nocturnal Enuresis | Phase 3 | Completed | Ferring Pharmaceuticals | 89 | 2010-01-01 | 2011-11-02 |
| Prenatal Pelvic Floor Prevention (3PN) Pelvic floor muscle training with physiotherapist, Written information about kegel exercises - Urinary Incontinence, Anal Incontinence | Phase 3 | Completed | Centre Hospitalier Universitaire de la Réunion | 280 | 2007-11-01 | 2013-07-26 |
| A Study to Evaluate Topical Phenylephrine Gel in the Management of Faecal Incontinence 10% Phenylephrine hydrochloride gel - Faecal Incontinence | Phase 3 | Withdrawn | S.L.A. Pharma AG | 2007-02-01 | 2015-05-19 |
Encopresis (7) · Nocturnal Enuresis (7) · Urinary Incontinence (4) · Fecal Incontinence (3) · Constipation (2) · Lower Urinary Tract Symptoms (2) · Urinary Incontinence, Stress (2) · Urologic Diseases (2) · Autism Spectrum Disorder (1) · Diurnal Enuresis (1) · Gastrointestinal Diseases (1) · Intestinal Diseases (1) · Neurogenic Bowel (1) · Pelvic Pain (1) · Rectal Diseases (1)
Behavior (15) · Behavioral Symptoms (15) · Mental Disorders (15) · Pathological Conditions, Signs and Symptoms (10) · Signs and Symptoms (10) · Female Urogenital Diseases (9) · Female Urogenital Diseases and Pregnancy Complications (9) · Male Urogenital Diseases (9) · Urination Disorders (9) · Urogenital Diseases (9) · Enuresis (8) · Signs and Symptoms, Digestive (7) · Urologic Diseases (7) · Urological Manifestations (4)
Deamino Arginine Vasopressin (3) · mirabegron (2) · Cholinergic Antagonists (1) · Fluoxetine (1) · Glycopyrrolate (1) · Iontophoresis (1) · Metronidazole (1) · Physical Therapists (1) · Solifenacin Succinate (1) · Therapeutics (1) · oxybutynin (1)
Cook MyoSite (3) · Mansoura University (2) · Centre Hospitalier Universitaire de la Réunion (1) · Emory University (1) · Ferring Pharmaceuticals (1) · Fr Muller Homoeopathic Medical College (1) · Hormozgan University of Medical Sciences (1) · James J. Peters Veterans Affairs Medical Center (1) · Queen Mary University of London (1) · S.L.A. Pharma AG (1) · University Hospital, Rouen (1) · University of Aarhus (1)
United States (4) · Egypt (2) · France (2) · United Kingdom (2) · Denmark (1) · India (1) · Iran (1) · Japan (1)
Melissa Kaufman, M.D., Ph.D. (2) · Ahmed Abdelhalem (1) · Christopher P Cardozo, MD (1) · Hamidreza Mahboobi, M.D (1) · Jyoshna Shivaprasad, MD (Hom) (1) · Luise Borch, MD, PhD (1) · Mahmoud Elkenawy (1) · Ron Jankowski, PhD (1) · Susan Clark, MD FRCS (1) · Tamer El-sayed Helmy (1)
PMID 20006865, PMID 26241428, PMID 27123229, PMID 28208214, PMID 28763464, PMID 30216627, PMID 32378735, PMID 40570329, PMID 40728007